While our core practice centers on FDA-approved indications, we also acknowledge and monitor current research interests concerning investigational conditions. The inclusion of these conditions on our website reflects the ongoing scientific exploration and the potential future applications of HBOT. It is crucial to understand that this reflects current research interests and not an endorsement of treatment for these conditions at this time. We emphasize that available studies for these investigational uses remain limited, underscoring the critical need for additional funding to support high-quality, rigorous research.
We are committed to transparency and continuous learning. Our website is regularly updated with new literature and findings as they become available, ensuring our community has access to the most current scientific understanding. Furthermore, HOPE For Healing Institute a 501(c)(3) charitable nonprofit organization, plays a vital role in advancing this field. Alongside our dedicated team of physicians, our Non-Profit stands ready to participate in robust, double-blind, peer-reviewed clinical studies. We believe that such rigorous research is essential to further validate and advance this transformative medical modality.
It is important to clarify the concept of 'off-label' use in medical practice. Licensed physicians are legally permitted to prescribe hyperbaric oxygen therapy, utilizing FDA-cleared chambers, for conditions that extend beyond their officially approved indications. This practice, commonly referred to as 'off-label' use, is a widely accepted and consistent component of standard medical practice guidelines across various specialties.
Key Principles of Off-Label HBOT:
• Adjunctive Therapy: Hyperbaric oxygen therapy, whether for approved or off-label indications, is primarily intended as an adjunctive therapy. This means it is designed to complement and support conventional medical treatments, not to replace them. Traditional medical care therapies should always be considered and implemented first.
• When Conventional Treatments Fall Short: HBOT may be considered as an adjunctive treatment in situations where conventional treatments have proven insufficient or ineffective.
This can occur due to various factors, including:
o Medication Allergies: When patients experience severe allergic reactions to standard medications.
o Drug Resistance: In cases where infectious agents or disease processes have developed resistance to conventional pharmacological interventions.
o Multi-System Failure: For patients presenting with complex conditions affecting multiple organ systems, where conventional approaches may be limited.
o Acute Conditions: In critical or acute medical situations where HBOT may offer a supportive therapeutic benefit.
Physician Discretion and Patient Assessment: The decision regarding the appropriateness and timing of HBOT, particularly for off-label uses, rests solely with a qualified physician or a collaborative medical team.
This decision is always based on a thorough and individualized patient assessment, taking into account their unique medical history, current condition, potential risks, and overall medical necessity.
Our physicians conduct comprehensive evaluations to ensure that HBOT is a suitable and beneficial component of a patient's treatment plan.
Physician Directed Hyperbaric Oxygen Therapy
We primarily treat FDA approved conditions at our facility.
The inclusion of these Investigational Conditions reflects current research interests, not treatment endorsement. Available studies remain limited, highlighting the need for additional funding to support high-quality research. Our website will be updated with new literature as it becomes available. Our sister-entity, the H.O.P.E for healing institute, a 501(c)(3) charitable nonprofit organization, and our team of physicians stands ready to participate in rigorous double-blind, peer-reviewed clinical studies to advance this transformative medical research.
We primarily treat FDA approved conditions at our facility.
The inclusion of these Investigational Conditions reflects current research interests, not treatment endorsement. Available studies remain limited, highlighting the need for additional funding to support high-quality research. Our website will be updated with new literature as it becomes available. Our sister-entity, the H.O.P.E for healing institute, a 501(c)(3) charitable nonprofit organization, and our team of physicians stands ready to participate in rigorous double-blind, peer-reviewed clinical studies to advance this transformative medical research.
